Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · IEX Real-Time Price · USD
0.560
-0.011 (-1.86%)
At close: Jul 19, 2024, 4:00 PM
0.580
+0.020 (3.53%)
Pre-market: Jul 22, 2024, 7:26 AM EDT

TNXP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2008
Revenue
10.257.770000
Upgrade
Cost of Revenue
6.44.740000
Upgrade
Gross Profit
3.853.030000
Upgrade
Selling, General & Admin
36.6734.7530.2223.4714.3510.64
Upgrade
Research & Development
73.0186.6681.8868.8436.1618.19
Upgrade
Operating Expenses
109.68121.41112.0992.3150.5128.83
Upgrade
Operating Income
-105.83-118.38-112.09-92.31-50.51-28.83
Upgrade
Other Expense / Income
-7.24-1.72-1.87-0.03-0.05-0.21
Upgrade
Pretax Income
-98.59-116.66-110.22-92.29-50.46-28.62
Upgrade
Net Income
-98.59-116.66-110.22-92.29-50.46-28.62
Upgrade
Preferred Dividends
006.6601.712.47
Upgrade
Net Income Common
-98.59-116.66-116.88-92.29-52.17-31.09
Upgrade
Shares Outstanding (Basic)
310000
Upgrade
Shares Outstanding (Diluted)
310000
Upgrade
Shares Change
687.64%191.70%220.61%285.23%5788.45%1294.44%
Upgrade
EPS (Basic)
-132.48-219.20-640.32-1620.00-3520.00-123712.00
Upgrade
EPS (Diluted)
-132.48-219.20-640.32-1620.00-3520.00-123712.00
Upgrade
Free Cash Flow
-89.87-108.9-146.2-110.86-57.13-26.7
Upgrade
Free Cash Flow Per Share
-35.56-204.51-800.90-1947.15-3865.37-106231.03
Upgrade
Gross Margin
37.55%38.97%----
Upgrade
Operating Margin
-1032.48%-1523.94%----
Upgrade
Profit Margin
-961.87%-1501.78%----
Upgrade
Free Cash Flow Margin
-876.80%-1401.89%----
Upgrade
EBITDA
-93.98-112.37-108.97-92.24-50.44-28.59
Upgrade
EBITDA Margin
-916.92%-1446.54%----
Upgrade
Depreciation & Amortization
4.614.291.250.050.030.03
Upgrade
EBIT
-98.59-116.66-110.22-92.29-50.46-28.62
Upgrade
EBIT Margin
-961.87%-1501.78%----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).